PDFs by language
Our 24/7 cancer helpline provides support for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Chat live online
Select the Live Chat button at the bottom of the page
At our National Cancer Information Center trained Cancer Information Specialists can answer questions 24 hours a day, every day of the year to empower you with accurate, up-to-date information to help you make educated health decisions. We connect patients, caregivers, and family members with valuable services and resources.
Or ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
Liver cancer is a type of cancer that starts in the liver. Cancer starts when cells in the body begin to grow out of control. To learn more about how cancers start and spread, see What Is Cancer?
To understand liver cancer, it helps to know about the normal structure and function of the liver.
The liver is the largest internal organ. It lies under your right ribs just beneath your right lung. It has two lobes (sections).
The liver is made up mainly of cells called hepatocytes. It also has other types of cells, including cells that line its blood vessels and cells that line small tubes in the liver called bile ducts. The bile ducts carry bile from the liver to the gallbladder or directly to the intestines.
You cannot live without your liver. It has many important functions:
The different types of cells in the liver can form several types of malignant (cancerous) and benign (non-cancerous) tumors. These tumors have different causes, are treated differently, and have a different prognosis (outlook).
A cancer that starts in the liver is called primary liver cancer. There is more than one kind of primary liver cancer.
This is the most common form of liver cancer in adults.
Hepatocellular cancers can have different growth patterns:
Doctors can classify several subtypes of HCC. Most often these subtypes do not affect treatment or prognosis (outlook). But one of these subtypes, fibrolamellar, is important to recognize. It is rare, making up less than 1% of HCCs and is most often seen in women younger than age 35. Often the rest of the liver is not diseased. This subtype tends to have a better outlook than other forms of HCC.
Most of the rest of this content refers only to hepatocellular carcinoma and is called liver cancer.
About 10% to 20% of cancers that start in the liver are intrahepatic cholangiocarcinomas. These cancers start in the cells that line the small bile ducts (tubes that carry bile to the gallbladder) within the liver. Most cholangiocarcinomas, however, actually start in the bile ducts outside the liver.
Although the rest of this information is mainly about hepatocellular cancers, cholangiocarcinomas are often treated the same way. For more detailed information on this type of cancer, see Bile Duct Cancer.
These are rare cancers that begin in cells lining the blood vessels of the liver. People who have been exposed to vinyl chloride or to thorium dioxide (Thorotrast) are more likely to develop these cancers (see Liver cancer risk factors). Some other cases are thought to be caused by exposure to arsenic or radium, or to an inherited condition known as hereditary hemochromatosis. In about half of all cases, no likely cause can be identified.
These tumors grow quickly and are usually too widespread to be removed surgically by the time they are found. Chemotherapy and radiation therapy may help slow the disease, but these cancers are usually very hard to treat. These cancers are treated like other sarcomas. For more information, see Soft Tissue Sarcoma.
This is a very rare kind of cancer that develops in children, usually in those younger than 4 years old. The cells of hepatoblastoma are similar to fetal liver cells. About 2 out of 3 children with these tumors are treated successfully with surgery and chemotherapy, although the tumors are harder to treat if they have spread outside the liver.
Most of the time when cancer is found in the liver it did not start there but has spread (metastasized) from somewhere else in the body, such as the pancreas, colon, stomach, breast, or lung. Because this cancer has spread from its original (primary) site, it is called a secondary liver cancer. These tumors are named and treated based on their primary site (where they started). For example, cancer that started in the lung and spread to the liver is called lung cancer with spread to the liver, not liver cancer. It is also treated as lung cancer.
In the United States and Europe, secondary (metastatic) liver tumors are more common than primary liver cancer. The opposite is true for many areas of Asia and Africa.
For more information on liver metastases from different types of cancer, see specific cancer types, as well as Advanced Cancer.
Benign tumors sometimes grow large enough to cause problems, but they do not grow into nearby tissues or spread to distant parts of the body. If they need to be treated, the patient can usually be cured with surgery.
The most common type of benign liver tumor, hemangiomas, start in blood vessels. Most hemangiomas of the liver cause no symptoms and do not need treatment. But some may bleed and need to be removed with surgery.
Hepatic adenoma is a benign tumor that starts from hepatocytes (the main type of liver cell). Most cause no symptoms and do not need treatment. But some eventually cause symptoms, such as pain or a lump in the abdomen (stomach area) or blood loss. Because there is a risk that the tumor could rupture (leading to severe blood loss) and a small risk that it could eventually develop into liver cancer, most experts will usually advise surgery to remove the tumor if possible.
Using certain drugs may increase the risk of getting these tumors. Women have a higher chance of having one of these tumors if they take birth control pills, although this is rare. Men who use anabolic steroids may also develop these tumors. Adenomas may shrink when these drugs are stopped.
Focal nodular hyperplasia (FNH) is a tumor-like growth made up of several cell types (hepatocytes, bile duct cells, and connective tissue cells). Although FNH tumors are benign, they might cause symptoms. It can be hard to tell them apart from true liver cancers and doctors sometimes remove them when the diagnosis is unclear.
Both hepatic adenomas and FNH tumors are more common in women than in men.
The American Cancer Society medical and editorial content team
Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as journalists, editors, and translators with extensive experience in medical writing.
Abou-Alfa GK, Jarnigan W, Dika IE, D’Angelica M, Lowery M, Brown K, et al. Ch. 77 - Liver and Bile Duct Cancer. In: Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE, eds. Abeloff’s Clinical Oncology. 6th ed. Philadelphia, Pa: Elsevier; 2020:1314–1341.
National Cancer Institute. Physician Data Query (PDQ). Adult Primary Liver Cancer Treatment. Accessed at https://www.cancer.gov/types/liver/hp/adult-liver-treatment-pdq on March 13, 2019.
National Cancer Institute. Physician Data Query (PDQ). Childhood Liver Cancer Symptoms, Tests, Prognosis, and Stages – Patient Version. Accessed at https://www.cancer.gov/types/liver/patient/about-child-liver-cancer-pdq#_1. on March 12, 2019.
Suriawinata A. Pathology of malignant tumors. UpToDate website. https://www.uptodate.com/contents/pathology-of-malignant-liver-tumors. Updated August 21, 2017. Accessed March 12, 2019.
Schwartz JM and Kruskal JB. Solid liver lesions: Differential diagnosis and evaluation. UpToDate website. https://www.uptodate.com/contents/solid-liver-lesions-differential-diagnosis-and-evaluation. Updated March 14, 2018. Accessed March 12, 2019.
Last Revised: April 1, 2019
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.